Results 201 to 210 of about 193,098 (314)

Nanomaterials for acute myeloid leukemia therapy: Current progress and future perspectives

Interdisciplinary Medicine, EarlyView.
Infographics of this review introducing the current treatment strategies, types of nanomaterials, and their advantages in AML treatment (Created with BioRender.com, a license purchased, accessed on March 26, 2024). Abstract Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy characterized by poor prognosis, high relapse rates ...
Jiarui Zhao, Jiaqi Cui, Lixuan Wang, Xinyi Shi, Jiayan Ding, Muhammad Farhan Sohail, Irshad Hussain, Qihui Liu, Fangfang Chen   +8 more
wiley   +1 more source

P1300: CLINICAL CHARACTERISTICS AND OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS WITH CORONAVIRUS DISEASE 2019 CAUSED BY THE OMICRON VARIANT: A PROSPECTIVE, OBSERVATIONAL COHORT STUDY

HemaSphere, 2023
Shuang Fan, Xiaodong Mo, Xiaohui Zhang, Lanping Xu, Yu Wang, Chenhua Yan, Huan Chen, Yuanyuan Zhang, Yifei Cheng, Yuqian Sun, Yuhong Chen, Yao Chen, Wei Han, Jingzhi Wang, Fengrong Wang, Zhengli Xu, Xiaojun Huang   +16 more
doaj   +1 more source

Hematopoietic stem cell transplantation: current status of old issues. [PDF]

, 2001
Neena Kapoor
openalex   +1 more source

Antifungal Resistance Among Candida Species: Diagnostic and Clinical Challenges in Specialized Cancer Care Hospital of Lahore

Journal of Clinical Laboratory Analysis, EarlyView.
Consumption of antifungals showed a declining trend, with the highest consumption of oral voriconazole (mean DOT/1000 pt. days 18653.49) and oral fluconazole (mean DOT/1000 pt. days 15258.14). Candida albicans was the most isolated pathogen 768 (53.60%) and among all Candida species, major resistance was found in Candida tropicalis 58 (4.05%).
Zunaira Akbar, Muhammad Aamir, Zikria Saleem, Muhammad Rehan Khan Niazi, Hasan Ejaz, Muharib Alruwaili, Khalid Abosalif   +6 more
wiley   +1 more source

Feasibility and effects of the telerehabilitation program during hematopoietic stem cell transplantation. [PDF]

Medicine (Baltimore)
Kim DY, Choi J, Kim CR, Lee Y, Kim Y, Jo JC.   +5 more
europepmc   +1 more source

Outcomes in patients undergoing hematopoietic stem cell transplantation for myelodysplastic syndromes. [PDF]

Blood Cell Ther
Karumathil S, Kulkarni U, Selvarajan S, Lionel S, Devasia AJ, Aboobacker FN, Lakshmi KM, Korula A, Srivastava A, Abraham A, Mathews V, George B.   +11 more
europepmc   +1 more source

Genetic protection of repopulating hematopoietic cells with an improved MDR1‐retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice [PDF]

, 2002
Alexander Carpinteiro, Stefan Peinert, Wolfram Ostertag, Axel R. Zander, Dieter K. Hossfeld, Klaus Kühlcke, Hans‐Georg Eckert, Christopher Baum, Susanna Hegewisch‐Becker   +8 more
openalex   +1 more source

Advances in allogeneic hematopoietic stem cell transplantation for Langerhans cell histiocytosis in children. [PDF]

Front Immunol
Meng G, Feng S, Wang Y.
europepmc   +1 more source

Challenges in Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation, 2010
openaire   +3 more sources

Model-Based Prediction of Clinically Relevant Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation. [PDF]

Clin Pharmacol Ther
Götz KM, Turki AT, Och K, Selzer D, Brossette C, Graf N, Rauch J, Theobald S, Braun Y, Rohm K, Weiler G, Rüdesheim S, Schwab M, Eisenberg L, Pfeifer N, Kiefer S, Schwarz U, Riede C, Smola S, Beelen DW, Kaddu-Mulindwa D, Rissland J, Bittenbring J, Lehr T.   +23 more
europepmc   +1 more source